In This Article:
Koninklijke Philips (AMS:PHIA) Full Year 2024 Results
Key Financial Results
-
Revenue: €18.0b (flat on FY 2023).
-
Net loss: €844.0m (loss widened by 85% from FY 2023).
-
€0.90 loss per share (further deteriorated from €0.49 loss in FY 2023).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Koninklijke Philips EPS Misses Expectations
Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates significantly.
The primary driver behind last 12 months revenue was the Diagnosis & Treatment Businesses segment contributing a total revenue of €8.79b (49% of total revenue). Notably, cost of sales worth €10.2b amounted to 57% of total revenue thereby underscoring the impact on earnings. The largest operating expense was Sales & Marketing costs, amounting to €4.49b (52% of total expenses). Explore how PHIA's revenue and expenses shape its earnings.
Looking ahead, revenue is forecast to grow 4.7% p.a. on average during the next 3 years, compared to a 7.2% growth forecast for the Medical Equipment industry in Europe.
Performance of the market in the Netherlands.
The company's shares are down 10% from a week ago.
Risk Analysis
Be aware that Koninklijke Philips is showing 2 warning signs in our investment analysis and 1 of those is a bit concerning...
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.